 Home > Medical News > Latest Medical News > Bozhiyan newly introduced two senior talents to create a leading drug delivery technology platform

Bozhiyan newly introduced two senior talents to create a leading drug delivery technology platform

 Last Update: 2021-10-09
 Source: Internet
 Author: User

Tags

number 6 plastic

ups business address

research paper cover

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Recently, Bozhiyan has newly introduced two senior management talents.

Mr.

New Vice President of Bo Zhiyan

2021 Nian 9 Yue 30 days, Mr.

Chief Financial Officer and Secretary of the Board

2021 Nian 7 Yue 27 days, Mr.

Bozhiyanxin has been adhering to its mission since its establishment, and is committed to bringing better medicines to the world.

It is currently in the period of rapid development and growth of Bozhiyan.

Ms.

Bozhiyanxin is a leading domestic drug delivery technology platform enterprise, specializing in complex drug formulations (sustained and controlled release formulations, double-layer multi-layer formulations, long-acting injections), special drug formulations (oral instant formulations, patches, nasal sprays) pediatric formulation), solubilized pharmaceutical preparation (spray-drying nanocrystals, since microemulsions, inclusion, micellar solubilization), high activity drug formulation (HP DP) and the like

Business Contact

Switchboard: 400-855-9019

Address: Building 1, Lane 647, Songtao Road, Pudong New Area, Shanghai

Xinlitai Pharmaceutical

Xinlitai Pharmaceutical is a subsidiary of Bozhiyan and has a research and development base in Shanghai Lingang

Chengdu Runze Pharmaceutical Technology Development Co.
, Ltd.
is a professional clinical research CRO company established in 2013.
The company is located in Chengdu, a major place in the west.
There are many GCP institutions with high clinical technology level represented by West China.
It can cover the entire central and western regions such as the central, southwest, and northwest
.
The company has good expert resources and core team, and has accumulated rich experience in clinical bioequivalence experiments, phase I-IV clinical research of drugs, and clinical research of medical devices
.
Business Contact: Mr.
Tan: 13980732663 Mr.
Xiao: 18108021731 Landline: 028-8559-0110

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.